<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>latham &amp; watkins - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/latham-watkins/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/latham-watkins/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Fri, 10 Jul 2020 05:01:29 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>latham &amp; watkins - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/latham-watkins/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Huion svela gli ultimissimi Kamvas 22 e Kamvas 22 Plus per conferire potere agli artisti di tutto il mondo </title>
		<link>https://www.newpharmaitaly.it/huion-svela-gli-ultimissimi-kamvas-22-e-kamvas-22-plus-per-conferire-potere-agli-artisti-di-tutto-il-mondo/</link>
					<comments>https://www.newpharmaitaly.it/huion-svela-gli-ultimissimi-kamvas-22-e-kamvas-22-plus-per-conferire-potere-agli-artisti-di-tutto-il-mondo/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Fri, 10 Jul 2020 05:01:29 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[acquisizione]]></category>
		<category><![CDATA[closing]]></category>
		<category><![CDATA[latham & watkins]]></category>
		<category><![CDATA[surface]]></category>
		<category><![CDATA[TA Associates]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/cultura-e-tempo-libero/2020/07/10/huion-svela-gli-ultimissimi-kamvas-kamvas-plus-per-conferire-potere-agli-artisti-tutto-mondo_YvTkgJUQrrqOmV6mAiGuKJ.html</guid>

					<description><![CDATA[<p>SHENZHEN, Cina, 10 luglio 2020 /PRNewswire/ -- Huion, uno dei principali produttori di dispositivi di input grafico, ha lanciato oggi due display a penna da 21,5 pollici: Kamvas 22 e la sua versione con configurazione più avanzata, Kamvas 22 Plus. Questi...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/huion-svela-gli-ultimissimi-kamvas-22-e-kamvas-22-plus-per-conferire-potere-agli-artisti-di-tutto-il-mondo/">Huion svela gli ultimissimi Kamvas 22 e Kamvas 22 Plus per conferire potere agli artisti di tutto il mondo </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/huion-svela-gli-ultimissimi-kamvas-22-e-kamvas-22-plus-per-conferire-potere-agli-artisti-di-tutto-il-mondo/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Cancer Research UK and Abcam Launch Custom Partnership to Accelerate Cancer Research </title>
		<link>https://www.newpharmaitaly.it/cancer-research-uk-and-abcam-launch-custom-partnership-to-accelerate-cancer-research/</link>
					<comments>https://www.newpharmaitaly.it/cancer-research-uk-and-abcam-launch-custom-partnership-to-accelerate-cancer-research/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Tue, 07 Jul 2020 06:01:15 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[emissione obbligazionaria]]></category>
		<category><![CDATA[latham & watkins]]></category>
		<category><![CDATA[masmovil]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/salute-e-benessere/2020/07/07/cancer-research-and-abcam-launch-custom-partnership-accelerate-cancer-research_IZIqicoMxkzK166K7QYxAI.html</guid>

					<description><![CDATA[<p>-  Long-term partnership to facilitate cancer research through development of custom antibodies -  Agreement to enable global access to resulting reagents and potential diagnostics  LONDON and CAMBRIDGE, England, July 7, 2020 /PRNewswire/ -- Today, Cancer Research UK, the world's largest independent funder of...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/cancer-research-uk-and-abcam-launch-custom-partnership-to-accelerate-cancer-research/">Cancer Research UK and Abcam Launch Custom Partnership to Accelerate Cancer Research </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/cancer-research-uk-and-abcam-launch-custom-partnership-to-accelerate-cancer-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>OKEx Announces Launch of Its Beacon Program &#8211; Mentorship and Masterclass Series for the European Region </title>
		<link>https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/</link>
					<comments>https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Wed, 27 May 2020 07:13:17 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[Antonio Coletti]]></category>
		<category><![CDATA[bond]]></category>
		<category><![CDATA[capital markets]]></category>
		<category><![CDATA[Chiomenti]]></category>
		<category><![CDATA[emissione obbligazionaria]]></category>
		<category><![CDATA[latham & watkins]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/2020/05/27/okex-announces-launch-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region_8B5Tb0Y0Q4VlboC70bEuHK.html</guid>

					<description><![CDATA[<p>VALLETTA, Malta, May 27, 2020 /PRNewswire/ -- OKEx (www.okex.com), the world's largest cryptocurrency spot and derivatives exchange, announces the launch of its OKEx Beacon Program, a Masterclass and Mentorship series specifically for the European region, today. The program consists of a combination...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/">OKEx Announces Launch of Its Beacon Program &#8211; Mentorship and Masterclass Series for the European Region </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/okex-announces-launch-of-its-beacon-program-mentorship-and-masterclass-series-for-the-european-region/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
